Submission Details
| 510(k) Number | K192125 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | August 06, 2019 |
| Decision Date | November 04, 2019 |
| Days to Decision | 90 days |
| Submission Type | Special |
| Review Panel | Cardiovascular (CV) |
| Summary | Summary PDF |
K192125 is an FDA 510(k) clearance for the Isolator Transpolar Pen, Isolator Long Pen TT, Isolator Linear Pen, a Surgical Device, For Cutting, Coagulation, And/or Ablation Of Tissue, Including Cardiac Tissue (Class II — Special Controls, product code OCL), submitted by AtriCure, Inc. (West Chester, US). The FDA issued a Cleared decision on November 4, 2019, 90 days after receiving the submission on August 6, 2019. This device falls under the Cardiovascular review panel. Regulated under 21 CFR 878.4400.
| 510(k) Number | K192125 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | August 06, 2019 |
| Decision Date | November 04, 2019 |
| Days to Decision | 90 days |
| Submission Type | Special |
| Review Panel | Cardiovascular (CV) |
| Summary | Summary PDF |
| Product Code | OCL — Surgical Device, For Cutting, Coagulation, And/or Ablation Of Tissue, Including Cardiac Tissue |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 878.4400 |
| Definition | Surgical Device For Cutting, Coagulation, And/or Ablation Of Tissue, Including Cardiac Tissue |